Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Differences in molecular profiles of glioblastomas according to location.

Literature DB >> 30445513

Differences in molecular profiles of glioblastomas according to location.

Craig Horbinski^1,2.

Abstract

Entities: Disease

Mesh：

Substances：
Isocitrate Dehydrogenase

Year: 2019 PMID： 30445513 PMCID： PMC6303431 DOI： 10.1093/neuonc/noy172

Source DB: PubMed Journal: Neuro Oncol ISSN： 1522-8517 Impact factor: 12.300

× No keyword cloud information.

6 in total

Review 1. To BRAF or not to BRAF: is that even a question anymore?

Authors: Craig Horbinski
Journal: J Neuropathol Exp Neurol Date: 2013-01 Impact factor: 3.685

2. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.

Authors: Quinn T Ostrom; Haley Gittleman; Peter Liao; Toni Vecchione-Koval; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal: Neuro Oncol Date: 2017-11-06 Impact factor: 12.300

3. Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.

Authors: Quinn T Ostrom; Peter M de Blank; Carol Kruchko; Claire M Petersen; Peter Liao; Jonathan L Finlay; Duncan S Stearns; Johannes E Wolff; Yingli Wolinsky; John J Letterio; Jill S Barnholtz-Sloan
Journal: Neuro Oncol Date: 2015-01 Impact factor: 12.300

4. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Authors: Dominik Sturm; Hendrik Witt; Volker Hovestadt; Dong-Anh Khuong-Quang; David T W Jones; Carolin Konermann; Elke Pfaff; Martje Tönjes; Martin Sill; Sebastian Bender; Marcel Kool; Marc Zapatka; Natalia Becker; Manuela Zucknick; Thomas Hielscher; Xiao-Yang Liu; Adam M Fontebasso; Marina Ryzhova; Steffen Albrecht; Karine Jacob; Marietta Wolter; Martin Ebinger; Martin U Schuhmann; Timothy van Meter; Michael C Frühwald; Holger Hauch; Arnulf Pekrun; Bernhard Radlwimmer; Tim Niehues; Gregor von Komorowski; Matthias Dürken; Andreas E Kulozik; Jenny Madden; Andrew Donson; Nicholas K Foreman; Rachid Drissi; Maryam Fouladi; Wolfram Scheurlen; Andreas von Deimling; Camelia Monoranu; Wolfgang Roggendorf; Christel Herold-Mende; Andreas Unterberg; Christof M Kramm; Jörg Felsberg; Christian Hartmann; Benedikt Wiestler; Wolfgang Wick; Till Milde; Olaf Witt; Anders M Lindroth; Jeremy Schwartzentruber; Damien Faury; Adam Fleming; Magdalena Zakrzewska; Pawel P Liberski; Krzysztof Zakrzewski; Peter Hauser; Miklos Garami; Almos Klekner; Laszlo Bognar; Sorana Morrissy; Florence Cavalli; Michael D Taylor; Peter van Sluis; Jan Koster; Rogier Versteeg; Richard Volckmann; Tom Mikkelsen; Kenneth Aldape; Guido Reifenberger; V Peter Collins; Jacek Majewski; Andrey Korshunov; Peter Lichter; Christoph Plass; Nada Jabado; Stefan M Pfister
Journal: Cancer Cell Date: 2012-10-16 Impact factor: 31.743

Review 5. What do we know about IDH1/2 mutations so far, and how do we use it?

Authors: Craig Horbinski
Journal: Acta Neuropathol Date: 2013-03-20 Impact factor: 15.887

6. H3.3^K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas.

Authors: Manav Pathania; Nicolas De Jay; Nicola Maestro; Ashot S Harutyunyan; Justyna Nitarska; Pirasteh Pahlavan; Stephen Henderson; Leonie G Mikael; Angela Richard-Londt; Ying Zhang; Joana R Costa; Steven Hébert; Sima Khazaei; Nisreen Samir Ibrahim; Javier Herrero; Antonella Riccio; Steffen Albrecht; Robin Ketteler; Sebastian Brandner; Claudia L Kleinman; Nada Jabado; Paolo Salomoni
Journal: Cancer Cell Date: 2017-10-26 Impact factor: 31.743